Entero Healthcare Solutions Ltd - 544122 - Clarification On Investor Queries Relating To Profit Attributable To Owners Of The Company And Minority Interest For The Quarter Ended 31St March 2026
Entero Healthcare Solutions clarified investor queries regarding Q4 FY26 results. The company stated that profit attributable to owners was impacted by Rs. 11.4 crore in one-off costs, while an increase in non-controlling interest was due to the 51.51% acquisition of Anand Chemiceutics Private Limited.
May 28 2026 23:22:46
Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Entero Healthcare Solutions has made available the audio recording of its Investors/Analyst Earnings Call held for the audited financial results of Q4 FY26. The transcript will also be uploaded on the company's website in due course, providing full details of the discussion.
May 26 2026 15:28:00
Entero Healthcare Solutions Ltd - 544122 - The Board Approved The Re-Appointment Of Internal Auditor M/S. Ernst & Young LLP ('EY') For The Next Financial Year 2026-27.
Entero Healthcare Board approved its FY26 audited financial results, along with re-appointment of three Independent Directors and Internal Auditor. The board also fixed August 19, 2026 for its 8th Annual General Meeting and approved two small acquisitions.
May 25 2026 21:38:28
Entero Healthcare Solutions Ltd - 544122 - The Grant Of Fresh 7,300 (Seven Thousand Three Hundred) Employee Stock Options Under The Existing 'Entero Employee Stock Option Plan 2023'.
Entero Healthcare Board approved its FY26 audited financial results, along with re-appointment of three Independent Directors and Internal Auditor. The board also fixed August 19, 2026 for its 8th Annual General Meeting and approved two small acquisitions.
May 25 2026 21:31:42
Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Outcome Of Board Meeting May 25, 2026
Entero Healthcare Solutions reported Q4 FY26 cons. revenue up 11.9% YoY to ₹1,909.93 Cr and net profit up 33.2% to ₹45.13 Cr. The board also re-appointed three Independent Directors for five-year terms, re-appointed Ernst & Young LLP as internal auditor for FY27, and approved the acquisition of Vishal Surgicals for up to ₹9.21 Cr, expanding its pharmaceutical distribution business.
May 25 2026 21:05:15
Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
ICICI Prudential Mutual Fund has significantly reduced its shareholding in Entero Healthcare Solutions from 5.015% to 2.161%. This disposal of 12.41 lakh shares occurred through open market transactions.
May 23 2026 10:40:31
Read More